Landscapes / Companies
AP Biosciences Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 2
2 in Phase 1
Drugs
4
in active trials
Trials
4 active
4 since 2021
Drugs4
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | 1 Dec 2026soonPhase 1/2 trial completes | |||
| Next date | 1 Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2026Phase 1/2 trial completes | |||
| Next date | Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Locally Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer (NSCLC) and 2 more | ||||
| Open drug page | |||||
— |
Phase 1 | 27 Dec 2027Phase 1 trial completes | |||
| Next date | 27 Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Solid Tumours | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021